U.S. markets closed

GSK plc (GSK)

NYSE - Nasdaq Real Time Price. Currency in USD
36.57+0.58 (+1.61%)
At close: 04:00PM EST
36.55 -0.02 (-0.05%)
After hours: 07:43PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close35.99
Bid33.66 x 1100
Ask37.80 x 1100
Day's Range35.99 - 36.59
52 Week Range33.20 - 39.74
Avg. Volume3,695,600
Market Cap75.016B
Beta (5Y Monthly)0.29
PE Ratio (TTM)9.78
EPS (TTM)3.74
Earnings DateN/A
Forward Dividend & Yield1.40 (3.84%)
Ex-Dividend DateNov 16, 2023
1y Target Est39.88
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
10% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for GSK

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • GSK plc
    Analyst Report: GSK plcIn the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
    Fair Value
    Economic Moat
    last monthMorningstar
View more